<DOC>
	<DOC>NCT00175630</DOC>
	<brief_summary>This study evaluates the effect of a femoral nerve block on opioid requirements following anterior cruciate ligament (ACL) reconstruction. This is a double blind, prospective randomized controlled trial.</brief_summary>
	<brief_title>The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>Schedule for primary elective anterior cruciate ligament reconstruction Tolerance to bupivacaine Tolerance to nonsteroidal antiinflammatory drugs (NSAIDs) Informed consent Patients who received a femoral nerve block more than 1 hour prior to surgery Complex associated injuries or preexisting conditions that will delay time to ambulation Children with tibial avulsion fractures Allergic and/or sensitive to bupivacaine and/or NSAIDs 30% over ideal body weight Acute ACL reconstruction (done less than 2 weeks after injury) Preexisting femoral nerve injury Psychiatric patients on psychotropic agents History of drug or alcohol dependence or recreational drug use Refusal to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>ACL reconstruction</keyword>
	<keyword>morphine sparing</keyword>
	<keyword>preemptive analgesia</keyword>
	<keyword>Post-operative pain and post- operative opioid use</keyword>
</DOC>